BioCryst Pharmaceuticals | BCRX - Ebit





Ebit Изменить Дата
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Chugai Pharma JPY 202.95B 42.09B 2026-09
Daiichi Sankyo JPY 108.7B 23.6B 2026-09
DBV Technologies USD -64.8M 16.9M 2026-09
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Glaxosmithkline GBP 2.15B 157M 2026-09
Incyte USD -707.47M 1.41B 2026-09
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novavax USD 20.94M 100.32M 2025-12
PTC Therapeutics USD 146.03M 100.14M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09